NDC 59762-2440-07 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-2440
- Requested NDC
- 59762-2440-07
- Package NDCs from labels
- 59762-2440-7, 59762-2440-07
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Effective date
- 2025-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2025-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxazosin mesylate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2022-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-2440-7 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-2440 | DOXAZOSIN MESYLATE TABLET DOXAZOSIN TABLET [MYLAN PHARMACEUTICALS INC.] | 17 | Current NDC, 1 package rows | 20250511_6b887aa5-5edf-48c5-a480-dea8c35afa9d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-2440-7 | EA - Each | 59762-2440 | dfe318c2-6759-4b10-82c2-e30946549cae | 1 | 2023-02-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOXAZOSIN MESYLATE | ACTIVE INGREDIENT | 86P6PQK0MU | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| DOXAZOSIN | ACTIVE MOIETY | NW1291F1W8 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| B03 Sinus Relief | ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS | Apex Energetics Inc. | bad83f77-e9ae-7118-e053-2a95a90aa737 | 2025-12-31 | Warnings | J2B2A4N98G |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 7aeaa0e1-136c-444d-b66c-7a5a96fb3022 | 2025-12-05 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 445dc831-1960-4b25-e063-6294a90a6efd | 2025-11-24 | Warnings, Adverse reactions | NDA019668 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Upsher-Smith laboratories, LLC | b5d1c604-ce3b-4973-845f-9db267a945cd | 2025-11-12 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Sugar Cravings | CINNAMIC ACID, PHLORIDZINUM, ARGENTUM NITRICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, BEET SUGAR, DEXTROSE, D-RIBOSE, FRUCTOSE, LYCOPODIUM CLAVATUM, MAPLE SUGAR, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, MALVIN, ADRENOCORTICOTROPHIN, DYSENTERY BACILLUS, MORGAN GAERTNER | Dr. Donna Restivo DC | 401873ba-ae1b-4506-a2e8-c6c0e5ff27f5 | 2025-10-21 | Warnings | J2B2A4N98G |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | d42d2691-f25d-4dfc-99d0-3286d71480a4 | 2025-10-13 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 57f4a953-ad23-4a44-9956-c48aa5927132 | 2025-10-02 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | American Health Packaging | 3f4dc1a7-05e6-41d7-908c-30ce2677d87b | 2025-09-17 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | b4c974ad-cbd6-4811-ab48-461e7ffa99f7 | 2025-09-17 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| Dairy-Grain-Nightshade | IRIS VERS., SOLIDAGO, ANTIMON. CRUD., ARG. NIT., ARSENICUM ALB., AVENA, BAPTISIA, BELLADONNA, BRYONIA, CAPSICUM, CARDUUS BEN., CINCHONA, DULCAMARA, FAGOPYRUM, GELSEMIUM, HYOSCYAMUS, IPECAC., LAC VAC., LACHESIS, LYCOPODIUM, NAT. MUR., PHOS., PODOPH. PELT., PULSATILLA, RHUS TOX., SAC. LAC., SECALE, SEPIA, STRAMONIUM, TABACUM, TRITICUM, USTILAGO MAIDIS, VERBASCUM, LYCOPERSICUM, SOLANUM NIG., SOLANUM TUB., STIGMATA, TORULA CEREVISIAE. | Newton Laboratories, Inc. | 99fcbd61-ecc8-cf9d-e053-2995a90aebeb | 2025-07-25 | Warnings | J2B2A4N98G |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 3ab222b7-74cc-5343-e063-6294a90a9616 | 2025-07-24 | Warnings, Adverse reactions | NDA019668 71610-927-60 71610-927-80 71610-927-53 71610-927 197627 3ab22051-bf7b-5122-e063-6294a90a4f64 3ab222b7-74cc-5343-e063-6294a90a9616 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 30b709d6-c438-c721-e063-6294a90abd61 | 2025-03-19 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 2e5cd8cb-7d43-e7af-e063-6294a90a310e | 2025-02-17 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Dairy-Grain-Nightshades | IRIS VERS., SOLIDAGO, ANTIMON. CRUD., ARG. NIT., ARSENICUM ALB., AVENA, BAPTISIA, BELLADONNA, BRYONIA, CAPSICUM, CARDUUS BEN., CINCHONA, DULCAMARA, FAGOPYRUM, GELSEMIUM, HYOSCYAMUS, IPECAC., LAC VAC., LACHESIS, LYCOPODIUM, NAT. MUR., PHOS., PODOPH. PELT., PULSATILLA, RHUS TOX., SAC. LAC., SECALE, SEPIA, STRAMONIUM, TABACUM, TRITICUM, USTILAGO MAIDIS, VERBASCUM, LYCOPERSICUM, SOLANUM NIG., SOLANUM TUB., STIGMATA, TORULA CEREVISIAE. | Newton Laboratories, Inc. | 9ba83c60-35be-181a-e053-2a95a90a9895 | 2025-02-06 | Warnings | J2B2A4N98G |
| DOXAZOSIN | DOXAZOSIN | direct rx | b57cf33b-e0bd-54e9-e053-2a95a90a5a6a | 2025-01-17 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 88efdfb0-710f-768a-e053-2995a90aede4 | 2024-12-17 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Zydus Lifesciences Limited | ac889877-133c-4448-af5a-d77b3cbfe878 | 2024-11-28 | 197625 197628 197626 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.